Treanor Blog/News

Grand Opening and Dedication of Biological Vaccine Production Facility

2011-05-02 Posted By: Birgitta Reynolds

Boehringer Ingelheim Vetmedica, Inc. (BIVI) held a Grand Opening and Dedication Ceremony on May 2, 2011 to celebrate the new expansion to their Biological Vaccine Production Facility in St. Joseph Missouri. Treanor Life Sciences has been involved in this project since the inception, beginning with a feasibility study in 2009 for production expansion at their Gene Field Campus facilities. The 46,000 sq ft Bio-Expansion will allow BIVI to essentially double the production capacity of the facility. Currently the same design team is working on a comprehensive Master Plan for BIVI's all North American facilities.

Article Link
Left: BIVI CEO George Heidgerken opens the expansion of the $50M biotech production facility, Right: Dr Christian Klessen is honored for his role as head of operationsLeft: BIVI CEO George Heidgerken opens the expansion of the $50M biotech production facility, Right: Dr Christian Klessen is honored for his role as head of operations